Hollywood Studios Are Nervous About 2026 — And the Numbers Explain Exactly Why

Big Films Studios Are Nervous heading into 2026 is not abstract. It is not the vague anxiety of an industry worried about changing tastes or shifting demographics. It is the specific, data-backed alarm of an industry that missed its own lowered targets for the second consecutive year, watched 17,000 of its workers lose their jobs in a single calendar year, saw its most powerful streaming competitor announce an $82.7 billion bid to acquire one of its most historic studios — and then looked at its 2026 release calendar, packed wall-to-wall with franchise sequels and IP extensions, and asked itself a question it has been avoiding for years: what if audiences simply stop showing up?

This is not a story about movies being bad. Some of the best-reviewed films of 2025 performed adequately. The problem is more structural, more permanent, and more resistant to solution than any single good film can address. Hollywood built a system that depends on audiences choosing the cinema over everything else competing for their attention and money. That system is breaking down. The numbers say so. The studio executives know it. And 2026 — with its enormous slate of expensive franchise films — is the year that will determine whether the industry finds a new model or simply accelerates toward a reckoning it has been deferring since 2020.

The 2025 Numbers: How Bad Was It, Really?

The North American domestic box office ended 2025 at approximately $8.7 billion. Before the pandemic, the domestic market routinely generated $10–11 billion annually. The industry had spent several years treating $9 billion as the baseline target for recovery — not ambition, but bare minimum. Missing it twice in a row is no longer deniable as a blip.

What makes the $8.7 billion figure even more alarming is how it was reached. The revenue increase over 2024 was not driven by more people going to the cinema. It was driven by higher ticket prices and the growth of premium formats — IMAX, PLF, Dolby Cinema. Fewer people are going to the movies. They’re just paying more when they do. That is not a recovery. That is consolidation.

CNBC’s February 2026 analysis put the structural issue plainly: there were 112 wide releases in 2025 — still 6.6% below 2019 levels — but box office still lagged more than 20% behind pre-pandemic figures. The mid-budget film — dramas, comedies, romantic comedies and thrillers in the $15–90 million range — has almost entirely migrated to streaming. What remains in theatres is almost exclusively franchise tentpoles. And those tentpoles are increasingly failing.

2025’s Biggest Losers: The Films That Cost Studios Most

The pattern across these losses is not random. Films that deviated from audience expectation (Joker 2), films that arrived amid pre-release controversy (Snow White), films that required knowledge of extensive preceding content (multiple Marvel titles) — all performed below the financial thresholds needed to justify their production and marketing costs. The industry’s response to each individual failure was to explain it as a one-time exception. The accumulation of exceptions has become a trend.

Franchise Fatigue: Now Confirmed by Data, Not Just Feeling

For years, “franchise fatigue” was discussed as a risk — a theoretical future state that the industry might eventually face. The 2025 numbers confirm it has arrived. Paul Dergarabedian, head of marketplace trends at Comscore, described the studio calculation to CNBC:

The problem is that the bet is increasingly not paying off. Variety’s year-end analysis noted that “many of the movie business’s biggest franchises are showing signs of oversaturation or fatigue.” Even Avatar: Fire and Ash — James Cameron’s third film in the series — while posting strong IMAX numbers ($140 million on IMAX screens globally, a record), tracked below Avatar: The Way of Water’s comparable pace. If even Hollywood’s most reliable franchise is showing diminished returns, the warning sign is hard to dismiss.

The Three Structural Shifts Changing Hollywood Forever

The Netflix–Warner Bros. Merger: Cinema’s Existential Threat

Late 2025 produced what The Wrap called “the looming merger of market-leading Netflix with legacy brand Warner Bros.” Netflix announced an $82.7 billion deal to acquire Warner Bros. The deal is pending regulatory approval. Its implications for cinemas are significant enough that theatre chains have been described as viewing it as “nothing short of an existential threat.”

The specific threat: Netflix co-CEO Ted Sarandos has signalled that theatrical windows will “evolve” in a “more consumer-friendly direction.” He told Wall Street that he believes current windows “are too long.” The entertainment industry translation is precise: Netflix intends to shorten the period during which films play exclusively in cinemas before becoming available on its platform. A shortened window removes the audience’s primary incentive to buy a ticket rather than wait.

Paramount Sold. NBCU Split. The Studio System Is Restructuring in Real Time

The Netflix-WB deal is not the only major ownership change reshaping Hollywood. The Wrap’s January 2026 analysis documented a cascade of structural changes:

The Wrap’s industry columnist wrote with unusual bluntness: “A century-old business model has been disrupted, permanently, by the rise of streaming and tech’s takeover of what was once known as Hollywood.” This is not pessimism. It is the accurate description of a shift that has been happening for a decade and is now reaching its conclusions.

The 2026 Slate: Which Films Carry the Most Risk

Against this backdrop, the 2026 theatrical slate is almost entirely franchise-driven. Deadline projects $9 billion domestic for 2026 — but cautions the entire projection rests on the franchise films performing. Here is how the major releases stack up in terms of risk:

Reasons for Hope: What Could Actually Save 2026

The picture is not entirely bleak. Deadline projects $9 billion domestic for 2026 on the strength of the franchise slate — and a few genuine reasons for optimism exist alongside the structural concerns.

First: premium formats are growing. IMAX hit a record $1.28 billion globally in 2025. Premium large-format screens continue to provide the kind of event-cinema experience that streaming cannot replicate. Nolan’s The Odyssey, Avengers: Doomsday, and Dune: Part Three are all natural IMAX draws — and premium formats are where the theatrical business’s resilience is most visible.

Second: family animation remains reliable. Zootopia 2 earned $1.7 billion worldwide in 2025 — one of the year’s strongest performances. Toy Story 5 and Super Mario Galaxy Movie have the same built-in multigenerational appeal. PG-rated films with minimal content restrictions have become the safest theatrical bet in the current market.

Third: Christopher Nolan. His return with The Odyssey represents the single most compelling argument that original, director-driven blockbusters can still work at scale. Nolan’s track record — Dunkirk, Tenet (which performed in a pandemic), Oppenheimer ($950M globally) — is the strongest individual director argument for theatrical cinema’s continued relevance.

The Bollywood Parallel: India’s Own Box Office Anxiety

The Hollywood crisis has a direct Indian parallel that is less frequently discussed but equally real. The Indian theatrical market in 2025 produced its own version of franchise fatigue and star-power disappointment. The films that succeeded — Sarvam Maya (₹150 crore worldwide), South Indian blockbusters with strong word-of-mouth — did so on the strength of story and audience connection rather than star power or marketing scale alone.

The films that failed often shared a common characteristic: they asked audiences to show up based on star value rather than story value. When that bargain stopped working — when audiences decided that a familiar face was not sufficient reason to buy a ticket — the losses were significant. The biggest Indian theatrical successes of 2025 carried the same lesson as Hollywood’s: audiences will pay for an experience that feels worth their money and their time. They will not pay simply because the industry expects them to.

The OTT question is also identical in structure to the Hollywood one. When Sarvam Maya moved to JioHotstar 36 days after theatrical release, it demonstrated both the strength of the theatrical window (36 days of sustained revenue generation) and the pressure on that window (audiences who know the streaming date may defer attendance). The Indian industry is navigating the same calculation as Hollywood, with the same absence of a clean answer.

FAQs

Sources: CNBC — Franchise Fatigue & 2026 Risks (Jan 30, 2026) · Variety — Box Office Struggled in 2025 (Dec 29, 2025) · The Wrap — Hollywood Had a Bad 2025. How Much Worse in 2026? (Jan 5, 2026) · Deadline — Global Box Office 2025 Report (Jan 2, 2026) · That Park Place — 2025 Box Office Analysis (Jan 2, 2026) · That Park Place — 2026 Q1 Box Office Analysis · WebProNews — Franchise Fatigue Analysis (Jan 30, 2026)

Sanjana S

Content writer at Popcorn Review, specializing in movie reviews, box office insights, and film analysis. Passionate about bringing cinema stories to life.